Juliana idoyaga - Publications

Affiliations: 
Stanford University Medical School 

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sulczewski FB, Maqueda-Alfaro RA, Alcántara-Hernández M, Perez OA, Saravanan S, Yun TJ, Seong D, Arroyo Hornero R, Raquer-McKay HM, Esteva E, Lanzar ZR, Leylek RA, Adams NM, Das A, Rahman AH, ... ... Idoyaga J, et al. Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses. Nature Immunology. PMID 37414907 DOI: 10.1038/s41590-023-01545-7  0.337
2023 Tadepalli S, Clements DR, Saravanan S, Arroyo Hornero R, Lüdtke A, Blackmore B, Paulo JA, Gottfried-Blackmore A, Seong D, Park S, Chan L, Kopecky BJ, Liu Z, Ginhoux F, Lavine KJ, ... ... Idoyaga J, et al. Rapid recruitment and IFN-I-mediated activation of monocytes dictate focal radiotherapy efficacy. Science Immunology. 8: eadd7446. PMID 37294749 DOI: 10.1126/sciimmunol.add7446  0.549
2023 Arroyo Hornero R, Idoyaga J. Plasmacytoid dendritic cells: A dendritic cell in disguise. Molecular Immunology. 159: 38-45. PMID 37269733 DOI: 10.1016/j.molimm.2023.05.007  0.363
2023 Reizis B, Idoyaga J, Dalod M, Barrat F, Naik S, Trinchieri G, Tussiwand R, Cella M, Colonna M. Reclassification of plasmacytoid dendritic cells as innate lymphocytes is premature. Nature Reviews. Immunology. PMID 36959479 DOI: 10.1038/s41577-023-00864-y  0.341
2022 Feng J, Pucella JN, Jang G, Alcántara-Hernández M, Upadhaya S, Adams NM, Khodadadi-Jamayran A, Lau CM, Stoeckius M, Hao S, Smibert P, Tsirigos A, Idoyaga J, Reizis B. Clonal lineage tracing reveals shared origin of conventional and plasmacytoid dendritic cells. Immunity. PMID 35180378 DOI: 10.1016/j.immuni.2022.01.016  0.344
2021 Prokopi A, Tripp CH, Tummers B, Hornsteiner F, Spoeck S, Crawford JC, Clements DR, Efremova M, Hutter K, Bellmann L, Cappellano G, Cadilha BL, Kobold S, Boon L, Ortner D, ... ... Idoyaga J, et al. Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy. Journal For Immunotherapy of Cancer. 9. PMID 33408092 DOI: 10.1136/jitc-2020-000832  0.351
2019 Leylek R, Alcántara-Hernández M, Lanzar Z, Lüdtke A, Perez OA, Reizis B, Idoyaga J. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Reports. 29: 3736-3750.e8. PMID 31825848 DOI: 10.1016/J.Celrep.2019.11.042  0.404
2019 Leylek R, Idoyaga J. The versatile plasmacytoid dendritic cell: Function, heterogeneity, and plasticity. International Review of Cell and Molecular Biology. 349: 177-211. PMID 31759431 DOI: 10.1016/Bs.Ircmb.2019.10.002  0.377
2019 Saligrama N, Zhao F, Sikora MJ, Serratelli WS, Fernandes RA, Louis DM, Yao W, Ji X, Idoyaga J, Mahajan VB, Steinmetz LM, Chien YH, Hauser SL, Oksenberg JR, Garcia KC, et al. Opposing T cell responses in experimental autoimmune encephalomyelitis. Nature. PMID 31391585 DOI: 10.1038/S41586-019-1467-X  0.421
2018 Antonio-Herrera L, Badillo-Godinez O, Medina-Contreras O, Tepale-Segura A, García-Lozano A, Gutierrez-Xicotencatl L, Soldevila G, Esquivel-Guadarrama FR, Idoyaga J, Bonifaz LC. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination. Frontiers in Immunology. 9: 2212. PMID 30319653 DOI: 10.3389/Fimmu.2018.02212  0.504
2018 Gálvez-Cancino F, López E, Menares E, Díaz X, Flores C, Cáceres P, Hidalgo S, Chovar O, Alcántara-Hernández M, Borgna V, Varas-Godoy M, Salazar-Onfray F, Idoyaga J, Lladser A. Vaccination-induced skin-resident memory CD8 T cells mediate strong protection against cutaneous melanoma. Oncoimmunology. 7: e1442163. PMID 29900048 DOI: 10.1080/2162402X.2018.1442163  0.423
2017 Alcántara-Hernández M, Leylek R, Wagar LE, Engleman EG, Keler T, Marinkovich MP, Davis MM, Nolan GP, Idoyaga J. High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. Immunity. PMID 29221729 DOI: 10.1016/J.Immuni.2017.11.001  0.414
2017 Lüdtke A, Ruibal P, Wozniak DM, Pallasch E, Wurr S, Bockholt S, Gómez-Medina S, Qiu X, Kobinger GP, Rodríguez E, Günther S, Krasemann S, Idoyaga J, Oestereich L, Muñoz-Fontela C. Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination. Scientific Reports. 7: 43776. PMID 28256637 DOI: 10.1038/Srep43776  0.404
2017 Carden SE, Walker GT, Honeycutt J, Lugo K, Pham T, Jacobson A, Bouley D, Idoyaga J, Tsolis RM, Monack D. Pseudogenization of the Secreted Effector Gene sseI Confers Rapid Systemic Dissemination of S. Typhimurium ST313 within Migratory Dendritic Cells. Cell Host & Microbe. 21: 182-194. PMID 28182950 DOI: 10.1016/J.Chom.2017.01.009  0.348
2017 Cruz JL, Pérez-Girón JV, Lüdtke A, Gómez-Medina S, Ruibal P, Idoyaga J, Muñoz-Fontela C. Monocyte-derived dendritic cells enhance protection against secondary influenza challenge by controlling the switch in CD8(+) T-cell immunodominance. European Journal of Immunology. 47: 345-352. PMID 27859043 DOI: 10.1002/Eji.201646523  0.406
2016 Lüdtke A, Ruibal P, Becker-Ziaja B, Rottstegge M, Wozniak DM, Cabeza-Cabrerizo M, Thorenz A, Weller R, Kerber R, Idoyaga J, Magassouba N, Gabriel M, Günther S, Oestereich L, Muñoz-Fontela C. Ebola Virus Disease Is Characterized by Poor Activation and Reduced Levels of Circulating CD16+ Monocytes. The Journal of Infectious Diseases. PMID 27521367 DOI: 10.1093/Infdis/Jiw260  0.422
2016 Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N, Chakarov S, Rivera C, Hogstad B, Bosenberg M, Hashimoto D, et al. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. Immunity. 44: 924-38. PMID 27096321 DOI: 10.1016/J.Immuni.2016.03.012  0.726
2016 Price JG, Idoyaga J, Merad M. Reply to: "Subverting misconceptions about radiation therapy". Nature Immunology. 17: 345-6. PMID 27002832 DOI: 10.1038/Ni.3376  0.677
2016 Salmon H, Idoyaga J, Rahman A, Palucka AK, Bhardwaj N, Ginhoux F, Merad M. Abstract B058: Expansion and activation of CD103+ DC progenitors at the tumor site promote T cell accumulation in melanoma lesions and transform clinical response to BRAF and PD-L1 blockade Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B058  0.707
2016 Salmon H, Idoyaga J, Rahman A, Remark R, Gnjatic S, Bhardwaj N, Brody J, Palucka AK, Ginhoux F, Merad M. Abstract B015: Expansion and activation of CD103+dendritic cell progenitors at the tumor site transform tumor response to PD-L1 and BRAF inhibition Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-B015  0.711
2015 Price JG, Idoyaga J, Salmon H, Hogstad B, Bigarella CL, Ghaffari S, Leboeuf M, Merad M. CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation. Nature Immunology. 16: 1060-8. PMID 26343536 DOI: 10.1038/Ni.3270  0.736
2015 Silva-Sánchez A, Meza-Pérez S, Flores-Langarica A, Donis-Maturano L, Estrada-García I, Calderón-Amador J, Hernández-Pando R, Idoyaga J, Steinman RM, Flores-Romo L. ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis. Plos One. 10: e0124828. PMID 25915045 DOI: 10.1371/Journal.Pone.0124828  0.396
2015 Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. The Journal of Experimental Medicine. 212: 281. PMID 25646268 DOI: 10.1084/jem.2013097701202015c  0.717
2014 Godefroy E, Gallois A, Idoyaga J, Merad M, Tung N, Monu N, Saenger Y, Fu Y, Ravindran R, Pulendran B, Jotereau F, Trombetta S, Bhardwaj N. Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses. Cell Reports. 9: 1856-70. PMID 25466255 DOI: 10.1016/J.Celrep.2014.10.067  0.735
2014 Flacher V, Tripp CH, Mairhofer DG, Steinman RM, Stoitzner P, Idoyaga J, Romani N. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance. Embo Molecular Medicine. 6: 1191-204. PMID 25085878 DOI: 10.15252/Emmm.201303283  0.501
2014 Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. The Journal of Experimental Medicine. 211: 669-83. PMID 24638167 DOI: 10.1084/Jem.20130977  0.736
2014 Godefroy E, Gallois A, Idoyaga J, Jotereau F, Bhardwaj N. Abstract LB-252: Matrix metalloproteinase-2 dysregulate anti-tumor immunity Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-252  0.484
2013 Matos I, Mizenina O, Lubkin A, Steinman RM, Idoyaga J. Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity. Plos One. 8: e67453. PMID 23840706 DOI: 10.1371/Journal.Pone.0067453  0.477
2013 Barbuto S, Idoyaga J, Vila-Perelló M, Longhi MP, Breton G, Steinman RM, Muir TW. Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells. Nature Chemical Biology. 9: 250-6. PMID 23416331 DOI: 10.1038/Nchembio.1186  0.417
2013 Idoyaga J, Fiorese C, Zbytnuik L, Lubkin A, Miller J, Malissen B, Mucida D, Merad M, Steinman RM. Specialized role of migratory dendritic cells in peripheral tolerance induction. The Journal of Clinical Investigation. 123: 844-54. PMID 23298832 DOI: 10.1172/Jci65260  0.581
2013 Price J, Hogstad B, Idoyaga J, LeBoeuf M, Bigarella C, Ghaffari S, Merad M. Unraveling the Mechanisms of Langerhans Cell Irradiation Resistance International Journal of Radiation Oncology*Biology*Physics. 87: S111-S112. DOI: 10.1016/J.Ijrobp.2013.06.288  0.702
2012 Meredith MM, Liu K, Kamphorst AO, Idoyaga J, Yamane A, Guermonprez P, Rihn S, Yao KH, Silva IT, Oliveira TY, Skokos D, Casellas R, Nussenzweig MC. Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. The Journal of Experimental Medicine. 209: 1583-93. PMID 22851594 DOI: 10.1084/Jem.20121003  0.435
2012 Meredith MM, Liu K, Darrasse-Jeze G, Kamphorst AO, Schreiber HA, Guermonprez P, Idoyaga J, Cheong C, Yao KH, Niec RE, Nussenzweig MC. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. The Journal of Experimental Medicine. 209: 1153-65. PMID 22615130 DOI: 10.1084/Jem.20112675  0.425
2012 Billiard F, Lobry C, Darrasse-Jèze G, Waite J, Liu X, Mouquet H, DaNave A, Tait M, Idoyaga J, Leboeuf M, Kyratsous CA, Burton J, Kalter J, Klinakis A, Zhang W, et al. Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice. The Journal of Experimental Medicine. 209: 1011-28. PMID 22547652 DOI: 10.1084/Jem.20111615  0.614
2012 Flacher V, Tripp CH, Haid B, Kissenpfennig A, Malissen B, Stoitzner P, Idoyaga J, Romani N. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 188: 2146-55. PMID 22291181 DOI: 10.4049/Jimmunol.1004120  0.46
2012 Hemmi H, Zaidi N, Wang B, Matos I, Fiorese C, Lubkin A, Zbytnuik L, Suda K, Zhang K, Noda M, Kaisho T, Steinman RM, Idoyaga J. Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein. Journal of Immunology (Baltimore, Md. : 1950). 188: 1147-55. PMID 22210914 DOI: 10.4049/Jimmunol.1102541  0.482
2012 Trumpfheller C, Longhi MP, Caskey M, Idoyaga J, Bozzacco L, Keler T, Schlesinger SJ, Steinman RM. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity. Journal of Internal Medicine. 271: 183-92. PMID 22126373 DOI: 10.1111/J.1365-2796.2011.02496.X  0.384
2011 Idoyaga J, Steinman RM. SnapShot: Dendritic Cells. Cell. 146: 660-660.e2. PMID 21854989 DOI: 10.1016/J.Cell.2011.08.010  0.417
2011 Idoyaga J, Lubkin A, Fiorese C, Lahoud MH, Caminschi I, Huang Y, Rodriguez A, Clausen BE, Park CG, Trumpfheller C, Steinman RM. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proceedings of the National Academy of Sciences of the United States of America. 108: 2384-9. PMID 21262813 DOI: 10.1073/Pnas.1019547108  0.448
2010 Cheong C, Matos I, Choi JH, Dandamudi DB, Shrestha E, Longhi MP, Jeffrey KL, Anthony RM, Kluger C, Nchinda G, Koh H, Rodriguez A, Idoyaga J, Pack M, Velinzon K, et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell. 143: 416-29. PMID 21029863 DOI: 10.1016/J.Cell.2010.09.039  0.501
2010 Romani N, Thurnher M, Idoyaga J, Steinman RM, Flacher V. Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy. Immunology and Cell Biology. 88: 424-30. PMID 20368713 DOI: 10.1038/Icb.2010.39  0.427
2010 Steinman RM, Idoyaga J. Features of the dendritic cell lineage. Immunological Reviews. 234: 5-17. PMID 20193008 DOI: 10.1111/J.0105-2896.2009.00888.X  0.366
2010 Flacher V, Tripp CH, Stoitzner P, Haid B, Ebner S, Del Frari B, Koch F, Park CG, Steinman RM, Idoyaga J, Romani N. Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. The Journal of Investigative Dermatology. 130: 755-62. PMID 19890348 DOI: 10.1038/Jid.2009.343  0.467
2009 Gottfried-Blackmore A, Kaunzner UW, Idoyaga J, Felger JC, McEwen BS, Bulloch K. Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 20918-23. PMID 19906988 DOI: 10.1073/Pnas.0911509106  0.468
2009 Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, Salazar AM, Colonna M, Steinman RM. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. The Journal of Experimental Medicine. 206: 1589-602. PMID 19564349 DOI: 10.1084/Jem.20090247  0.455
2009 Idoyaga J, Suda N, Suda K, Park CG, Steinman RM. Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proceedings of the National Academy of Sciences of the United States of America. 106: 1524-9. PMID 19168629 DOI: 10.1073/Pnas.0812247106  0.486
2009 Hemmi H, Idoyaga J, Suda K, Suda N, Kennedy K, Noda M, Aderem A, Steinman RM. A new triggering receptor expressed on myeloid cells (Trem) family member, Trem-like 4, binds to dead cells and is a DNAX activation protein 12-linked marker for subsets of mouse macrophages and dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 1278-86. PMID 19155473 DOI: 10.4049/Jimmunol.182.3.1278  0.441
2008 Idoyaga J, Cheong C, Suda K, Suda N, Kim JY, Lee H, Park CG, Steinman RM. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. Journal of Immunology (Baltimore, Md. : 1950). 180: 3647-50. PMID 18322168 DOI: 10.4049/Jimmunol.180.6.3647  0.451
2007 Cheong C, Idoyaga J, Do Y, Pack M, Park SH, Lee H, Kang YS, Choi JH, Kim JY, Bonito A, Inaba K, Yamazaki S, Steinman RM, Park CG. Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207. Journal of Immunological Methods. 324: 48-62. PMID 17553520 DOI: 10.1016/J.Jim.2007.05.001  0.417
2007 Idoyaga J, Moreno J, Bonifaz L. Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands. Cancer Immunology, Immunotherapy : Cii. 56: 1237-50. PMID 17237931 DOI: 10.1007/S00262-006-0275-Y  0.467
2005 Liu K, Idoyaga J, Charalambous A, Fujii S, Bonito A, Mordoh J, Wainstok R, Bai XF, Liu Y, Steinman RM. Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells. The Journal of Experimental Medicine. 202: 1507-16. PMID 16330814 DOI: 10.1084/Jem.20050956  0.538
2003 Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. Journal of Immunology (Baltimore, Md. : 1950). 171: 5940-7. PMID 14634105 DOI: 10.4049/Jimmunol.171.11.5940  0.527
Show low-probability matches.